Please login to the form below

Not currently logged in
Email:
Password:

Amgen veteran Kurt Gustafson joins Spectrum as CFO

Biotech also creates new senior financial position for Brett Scott

Spectrum Kurt GustafsonSpectrum Pharmaceuticals has appointed Kurt Gustafson as its executive VP, chief financial officer and principal accounting officer.

He joins Spectrum from fellow US biotech Halozyme Therapeutics, where he served as VP and chief financial officer.

Prior to this role, he spent more than 18 years at Amgen, holding such positions as chief financial office of Amgen International and VP finance.

In addition to Gustafson's appointment, Spectrum also announced that the company's senior VP and acting chief financial officer Brett Scott has been appointed to the newly-created role of senior VP of finance.

Dr Rajesh Shrotriya, chairman, CEO and president of Spectrum, explained why the company had created the new role and appointed Gustafson.

"We believe this is a time of rapid growth at Spectrum, and the business is becoming more complex,” he said.

“Kurt brings in over 20 years of experience in finance and is a key addition to our already strong management team. We look forward to working with Kurt as we continue to build our business and execute our goals."

7th June 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics